The New England journal of medicine, 2022-09, Vol.387 (13), p.1173-1184
- Han, MeiLan K.
- Ye, Wen
- Wang, Di
- White, Emily
- Arjomandi, Mehrdad
- Barjaktarevic, Igor Z.
- Brown, Stacey-Ann
- Buhr, Russell G.
- Comellas, Alejandro P.
- Cooper, Christopher B.
- Criner, Gerard J.
- Dransfield, Mark T.
- Drescher, Frank
- Folz, Rodney J.
- Hansel, Nadia N.
- Kalhan, Ravi
- Kaner, Robert J.
- Kanner, Richard E.
- Krishnan, Jerry A.
- Lazarus, Stephen C.
- Maddipati, Veeranna
- Martinez, Fernando J.
- Mathews, Anne
- Meldrum, Catherine
- McEvoy, Charlene
- Nyunoya, Toru
- Rogers, Linda
- Stringer, William W.
- Wendt, Christine H.
- Wise, Robert A.
- Wisniewski, Stephen R.
- Sciurba, Frank C.
- Woodruff, Prescott G.
2022
Details
- Autor(en) / Beteiligte
- Han, MeiLan K.
- Ye, Wen
- Wang, Di
- White, Emily
- Arjomandi, Mehrdad
- Barjaktarevic, Igor Z.
- Brown, Stacey-Ann
- Buhr, Russell G.
- Comellas, Alejandro P.
- Cooper, Christopher B.
- Criner, Gerard J.
- Dransfield, Mark T.
- Drescher, Frank
- Folz, Rodney J.
- Hansel, Nadia N.
- Kalhan, Ravi
- Kaner, Robert J.
- Kanner, Richard E.
- Krishnan, Jerry A.
- Lazarus, Stephen C.
- Maddipati, Veeranna
- Martinez, Fernando J.
- Mathews, Anne
- Meldrum, Catherine
- McEvoy, Charlene
- Nyunoya, Toru
- Rogers, Linda
- Stringer, William W.
- Wendt, Christine H.
- Wise, Robert A.
- Wisniewski, Stephen R.
- Sciurba, Frank C.
- Woodruff, Prescott G.
- Titel
- Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function
- Ist Teil von
- The New England journal of medicine, 2022-09, Vol.387 (13), p.1173-1184
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2022
- Link zum Volltext
- Quelle
- Alma/SFX Local Collection
- Beschreibungen/Notizen
- This trial involving symptomatic, tobacco-exposed persons with preserved lung function on spirometry showed no benefit to the use of dual bronchodilator therapy.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2204752Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9741866
- Format
- –
- Schlagworte
- Adrenergic beta-2 Receptor Agonists - therapeutic use, Anti-Bacterial Agents - therapeutic use, Antibiotics, Bronchodilator agents, Bronchodilator Agents - therapeutic use, Bronchodilators, Care and treatment, Chronic obstructive pulmonary disease, Clinical Medicine, Clinical Medicine General, Clinical significance, COPD, Coronaviruses, COVID-19, Critical Care, Critical Care General, Drug dosages, Dyspnea, FDA approval, Forced Expiratory Volume, Glucocorticoids, Glucocorticoids - therapeutic use, Glycopyrrolate, Health aspects, Humans, Lung, Lung diseases, Nicotiana - adverse effects, Obstructive lung disease, Outpatient-Based Clinical Medicine, Pandemics, Placebos, Pulmonary, Pulmonary Disease, Chronic Obstructive - drug therapy, Pulmonary Disease, Chronic Obstructive - etiology, Pulmonary Disease, Chronic Obstructive - physiopathology, Pulmonary manifestations of general diseases, Respiration, Respiratory function, Smokers, Smoking, Spirometry, Testing, Tobacco, Treatment Outcome